Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 4
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Bleeding complications from the direct oral anticoagulants | Sholzberg M, Pavenski K, Shehata N, Cserti-Gazdewich C, Lin Y | 2015 | BMC Hematol | View Bleeding complications from the direct oral anticoagulants | Health care providers | Clinical research |
Bleeding complications in immune thrombocytopenia | Arnold DM | 2015 | Hematology Am Soc Hematol Educ Program | View Bleeding complications in immune thrombocytopenia | Health care providers | Clinical research |
Blood Administration | de Biasio L, Rymer T | 2017 | Clinical Guide to Transfusion | View Blood Administration | Health care providers | Other |
Blood and clots quizlet 1: Oral contraceptives and pulmonary embolism | Tseng E, Yeh C, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 1: Oral contraceptives and pulmonary embolism | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 2: Trauma in a patient on warfarin | Shih A, Tseng E, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 2: Trauma in a patient on warfarin | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 3: Procedures on warfarin | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 3: Procedures on warfarin | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 5: Should I screen my patient for occult cancer after unprovoked VTE? | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 5: Should I screen my patient for occult cancer after unprovoked VTE? | Health care providers | Benchmarking and standard setting |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |
Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Health care providers | Benchmarking and standard setting |
Blood and clots series: What are the risks of reversing DOAC-associated intracranial bleeding? | Shih A | 2018 | CanadiEM website | View Blood and clots series: What are the risks of reversing DOAC-associated intracranial bleeding? | Health care providers | Benchmarking and standard setting |
Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Health care providers | Benchmarking and standard setting |
Blood bag plasticizers influence red blood cell vesiculation rate without altering the lipid composition of the vesicles | Bicalho B, Serrano K, dos Santos Pereira A, Devine D, Acker J | 2016 | Transfus Med Hemother | View Blood bag plasticizers influence red blood cell vesiculation rate without altering the lipid composition of the vesicles | Researchers | Basic research |
Blood component transfusion in critically ill patients | McIntyre L, Tinmouth AT, Fergusson DA | 2013 | Curr Opin Crit Care | View Blood component transfusion in critically ill patients | Health care providers | Clinical research |
Blood components | Clarke G | 2017 | Clinical Guide to Transfusion | View Blood components | Health care providers | Benchmarking and standard setting |
Blood donation and testosterone replacement therapy | Chin-Yee B, Lazo-Langner A, Butler-Foster T, Hsia C, Chin-Yee I | 2017 | Transfusion | View Blood donation and testosterone replacement therapy | Health care providers | Clinical research |
Blood donation testing and the safety of the blood supply | Goldman M | 2017 | Practical Transfusion Medicine, 5th Edition | View Blood donation testing and the safety of the blood supply | Health care providers | Benchmarking and standard setting |
Blood donor characteristics on transfusion outcomes-should obesity be assessed in future clinical trials?-reply | Chasse M, Fergusson DA | 2017 | JAMA Intern Med | View Blood donor characteristics on transfusion outcomes-should obesity be assessed in future clinical trials?-reply | Researchers | Clinical research |
Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors | Saw CL, Hannach B, Petrazsko T, Nickerson P | 2013 | Transfusion | View Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors | Researchers | Clinical research |
Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study | Delaney M, Wikman A, van de Watering L, Schonewille H, Verdoes JP, Emery SP, Murphy MF, Staves J, Flach S, Arnold DM, Kaufman RM, Ziman A, Harm SK, Fung M, Eppes CS, Dunbar NM, Buser A, Meyer E, Savoia H, Abeysinghe P, Heddle N, Tinmouth A, Traore AN, Yazer MH, for the Best Collaborative | 2017 | Transfusion | View Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study | Researchers | Clinical research |
Blood groups and susceptibility to virus infection: new developments | Branch DR | 2010 | Curr Opin Hematol | View Blood groups and susceptibility to virus infection: new developments | Researchers | Basic research |
Blood: the basics | Chargé S, Hodgkinson KM | 2017 | Blood.ca website | View Blood: the basics | Health care providers | Other |
Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Walsh GM, Shih AW, Solh Z, Golder M, Schubert P, Fearon M, Sheffield WP | 2016 | Transfus Med Rev | View Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Health care providers | Other |
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Tseng E, Crowther MA, Hillis CM | 2016 | CMAJ | View Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Health care providers | Clinical research |
Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles | Bicalho B, Pereira AS, Acker JP | 2015 | Vox Sang | View Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles | Researchers | Basic research |
Cadherin 6 has a functional role in platelet aggregation and thrombus formation | Dunne E, Spring CM, Reheman A, Jin W, Berndt MC, Newman DK, Newman PJ, Ni H, Kenny D | 2012 | Arterioscler Thromb Vasc Biol | View Cadherin 6 has a functional role in platelet aggregation and thrombus formation | Researchers | Basic research |
Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer? | Veljkovic M, Branch DR, Dopsaj V, Veljkovic V, Veljkovic N, Glisic S, Colombatti A | 2011 | Med Hypotheses | View Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer? | Researchers | Basic research |
Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors | D'Aragon F, Dhanani S, Lamontagne F, Cook DJ, Burns K, Akhtar A, Chasse M, Frenette AJ, Keenan S, Lize JF, Kutsogiannis DJ, Kramer A, Hand LE, Arseneau E, Masse MH, Ribic C, Ball I, Baker A, Boyd G, Rochwerg B, Healey A, Hanna S, Guyatt GH, Meade MO | 2017 | BMJ Open | View Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors | Researchers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Researchers | Basic research |
Carbohydrate-based ice recrystallization inhibitors increase infectivity and thermostability of viral vectors | Ghobadloo SM, Balcerzak AK, Gargaun A, Muharemagic D, Mironov GG, Capicciotti CJ, Briard JG, Ben RN, Berezovski MV | 2014 | Sci Rep | View Carbohydrate-based ice recrystallization inhibitors increase infectivity and thermostability of viral vectors | Researchers | Basic research |
Cardiorespiratory pathogenesis of sickle cell disease in a mouse model | Ren J, Ding X, Trudel M, Greer JJ, MacLean JE | 2017 | Sci Rep | View Cardiorespiratory pathogenesis of sickle cell disease in a mouse model | Researchers | Basic research |
Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells: implications for clinical transplantation and gene therapy | Gul-Uludag H, Xu P, Marquez-Curtis LA, Xing J, Janowska-Wieczorek A, Chen J | 2012 | Stem Cells Dev | View Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells: implications for clinical transplantation and gene therapy | Researchers | Basic research |
CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia | Guo L, Kapur R, Aslam R, Speck ER, Zufferey A, Zhao Y, Kim M, Lazarus AH, Ni H, Semple JW | 2016 | Blood | View CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia | Researchers | Basic research |
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR | 2013 | AIDS | View CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Researchers | Basic research |
CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis | Mott PJ, Lazarus AH | 2013 | PLoS One | View CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis | Researchers | Basic research |
CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fc? Receptor– and Complement Receptor 3–Dependent Mechanisms | Amash A, Wang L, Wang Y, Bhakta V, Fairn GD, Hou M, Peng J, Sheffield WP, Lazarus AH | 2016 | J Immunol | View CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fc? Receptor– and Complement Receptor 3–Dependent Mechanisms | Researchers | Basic research |
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcgammaRIIb genetic disruption | Crow AR, Amash A, Lazarus AH | 2014 | Transfusion | View CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcgammaRIIb genetic disruption | Researchers | Basic research |
CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia | Qiu J, Liu X, Li X, Zhang X, Han P, Zhou H, Shao L, Hou Y, Min Y, Kong Z, Wang Y, Wei Y, Liu X, Ni H, Peng J, Hou M | 2016 | Sci Rep | View CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia | Researchers | Basic research |
CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia | Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L, Shi Y, Yougbaré I, Wang X, Zhu G, Chen P, Prudhomme GJ, Lazarus AH, Freedman J, Ni H | 2015 | Blood | View CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia | Researchers | Basic research |
Cell-based therapy using umbilical cord blood for novel indications in regenerative therapy and immune modulation: an updated systematic scoping review of the literature | Rizk M, Aziz J, Shorr R, Allan DS | 2017 | Biol Blood Marrow Transplant | View Cell-based therapy using umbilical cord blood for novel indications in regenerative therapy and immune modulation: an updated systematic scoping review of the literature | Researchers | Clinical research |
Cell-matrix interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. Fibrinogen-alginate microcapsules | Sayyar B, Dodd M, Marquez-Curtis L, Janowska-Wieczorek A, Hortelano G | 2014 | Artif Cells Nanomed Biotechnol | View Cell-matrix interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. Fibrinogen-alginate microcapsules | Researchers | Basic research |
Cellular immune dysfunction in immune thrombocytopenia (ITP) | McKenzie CGJ, Guo L, Freedman J, Semple JW | 2013 | Br J Haematol | View Cellular immune dysfunction in immune thrombocytopenia (ITP) | Researchers | Basic research |
Challenges in the management of the blood supply | Williamson LM, Devine DV | 2013 | Lancet | View Challenges in the management of the blood supply | Blood operators | Other |
Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study | Yazer MH, Jackson B, Beckman N, Chesneau S, Bowler P, Delaney M, Devine D, Field S, Germain M, Murphy MF, Sayers M, Shaz B, Shinar E, Takanashi M, Vassallo R, Wickenden C, Yahalom V, Land K, on behalf of the BEST Collaborative | 2016 | Transfusion | View Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study | Blood operators | New or improved product or process |
Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C | 2012 | Transfusion | View Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Health care providers | New or improved product or process |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
Changing the 30-min Rule in Canada: The Effect of Room Temperature on Bacterial Growth in Red Blood Cells | Ramirez-Arcos S, Kou Y, Ducas É, Thibault L | 2016 | Transfus Med Hemother | View Changing the 30-min Rule in Canada: The Effect of Room Temperature on Bacterial Growth in Red Blood Cells | Blood operators | Benchmarking and standard setting |
Changing trends in blood transfusion: an analysis of 244,013 hospitalizations | Shehata N, Forster A, Lawrence N, Rothwell DM, Fergusson D, Tinmouth A, Wilson K | 2014 | Transfusion | View Changing trends in blood transfusion: an analysis of 244,013 hospitalizations | Health care providers | Clinical research |
Chapter 33: Synthesis of N-(4-Methoxybenzyl)-2-(α-d-glucopyranosyl) acetamide | Roy R, Vidal S, Briard JG, Shiao TC, Ben RN | 2015 | Carbohydrate Chemistry: Proven Synthetic Methods, Volume 3 | View Chapter 33: Synthesis of N-(4-Methoxybenzyl)-2-(α-d-glucopyranosyl) acetamide | Researchers | Basic research |
Chapter 5 - Platelet microRNAs | Provost P | 2013 | Platelets (Third Edition) | View Chapter 5 - Platelet microRNAs | Researchers | Other |